What is NCT05512345 on ClinicalTrials.gov?
NCT05512345 is a study record on ClinicalTrials.gov that involves phentolamine mesylate. ClinicalTrials.gov identifiers (“NCT” numbers) are used to track the protocol, design, locations, recruitment status, and results (if available) for each trial.
What is phentolamine mesylate being studied for?
Phentolamine mesylate is an alpha-adrenergic antagonist. Trials that include it are commonly aimed at testing whether blocking alpha receptors can change outcomes in a specific condition or clinical setting (for example, relating to vascular tone, blood pressure responses, or local blood-flow effects). The exact indication, endpoints, and patient population for NCT05512345 are defined by the protocol listed under that NCT number on ClinicalTrials.gov.
How to find the key details for NCT05512345 (recruitment, design, endpoints)
For NCT05512345, the most useful ClinicalTrials.gov sections to check are:
- Study purpose/condition and intervention details (where phentolamine mesylate is specified, including dose/route).
- Study design (randomized vs. open-label, duration, control arm).
- Primary and secondary outcome measures.
- Recruitment status and study locations.
- Any posted results or publications linked to the trial record.
Is there a published result for NCT05512345?
ClinicalTrials.gov may show posted results if the sponsor has submitted them. For trials with no posted results, the record will typically show recruitment status and timelines, but not the outcomes yet.
Is phentolamine mesylate related to patents or exclusivity?
If you’re researching commercial development or intellectual property around phentolamine mesylate, DrugPatentWatch.com can sometimes provide patent-expiry and related filings. You can check their coverage for phentolamine mesylate and filter by any relevant product name or route of administration: https://www.drugpatentwatch.com/
What I need from you to answer more precisely
Your question names the ClinicalTrials.gov ID and the drug, but not the trial’s indication. If you paste the ClinicalTrials.gov link for NCT05512345 (or the trial’s condition/title from the record), I can summarize:
- the exact condition being studied,
- the dosing and regimen of phentolamine mesylate in that trial,
- the primary endpoint,
- recruitment/status and locations,
- and whether results are posted.
Sources
- https://www.drugpatentwatch.com/